r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with 293b cpd in 1 studies
Studies (r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid) | Trials (r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid) | Recent Studies (post-2010) (r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid) | Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) |
---|---|---|---|---|---|
17 | 4 | 9 | 100 | 0 | 16 |
Protein | Taxonomy | r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid (IC50) | 293b cpd (IC50) |
---|---|---|---|
Potassium voltage-gated channel subfamily KQT member 1 | Cavia porcellus (domestic guinea pig) | 5 | |
Potassium voltage-gated channel subfamily E member 1 | Homo sapiens (human) | 5 | |
Potassium voltage-gated channel subfamily KQT member 1 | Homo sapiens (human) | 5 | |
Nischarin | Homo sapiens (human) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wermuth, CG | 1 |
1 review(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and 293b cpd
Article | Year |
---|---|
Selective optimization of side activities: another way for drug discovery.
Topics: Animals; Biological Availability; Combinatorial Chemistry Techniques; Databases, Factual; Drug Design; Humans; Patents as Topic; Pharmaceutical Preparations; Structure-Activity Relationship | 2004 |